Recent Finacing
Recent Raise
Allogene Therapeutics is a San Francisco clinical-stage biotech developing off-the-shelf allogeneic CAR T therapies, including UCART19 (CD19) in Phase 1, leveraging healthy-donor cell inventories for scalable manufacturing.
